Prognostic significance of preoperative hyaluronic acid level in patients with hepatocellular carcinoma

HPB (Oxford). 2022 Apr;24(4):525-534. doi: 10.1016/j.hpb.2021.09.001. Epub 2021 Oct 1.

Abstract

Background: Serum hyaluronic acid (HA) levels are increased in patients with solid tumors, and may predict outcomes. However, as HA levels also correlate with the degree of liver fibrosis, the prognostic significance of serum HA levels in patients with hepatocellular carcinoma (HCC) is unclear.

Methods: A total of 656 consecutive patients who underwent hepatic resection for HCC were divided into two groups by serum HA level (high HA [≥200 ng/mL], n = 248; low HA [<200 ng/mL], n = 408). Clinicopathological characteristics and postoperative survival were compared between groups. Moreover, 1:1 propensity score matching analysis was applied to adjust characteristics between groups.

Results: Both the 5-year overall and relapse-free survival rates (OSR and RFSR) in the low HA group were significantly better than those in the high HA group (59.8% vs. 38.6%, respectively, p < 0.001 and 24.5% vs. 13.1%, respectively, p < 0.001). After propensity score matching, two comparable groups of 124 patients each were obtained. However, both the 5-year OSR and RFSR in the low HA group remained significantly better than those in the high HA group (57.4% vs. 38.3%, respectively, p = 0.006 and 22.5% vs. 14.7%, respectively, p = 0.003).

Conclusion: High preoperative HA level predicts poor postoperative survival of patients with HCC. undergoing hepatic resection.

MeSH terms

  • Carcinoma, Hepatocellular*
  • Hepatectomy / adverse effects
  • Humans
  • Hyaluronic Acid
  • Liver Neoplasms*
  • Neoplasm Recurrence, Local / surgery
  • Prognosis
  • Propensity Score
  • Retrospective Studies

Substances

  • Hyaluronic Acid